EML6
Echinoderm microtubule-associated protein-like 6
Also known as: EMAL6_HUMAN, FLJ42562
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZMW3
- Gene
- EML6
- Ensembl
- ENSG00000214595
- Chromosome
- 2
- Canonical length
- 1958 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Mitochondria
OverviewNCBI Gene
Predicted to enable microtubule binding activity. Predicted to be located in cytoplasm and microtubule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1958 residues, UniProt reviewed canonical sequence.
>Q6ZMW3|EML6
1 MADRTAPRCQ LRLEWVYGYR GHQCRNNLYY TAGKEVVYFV AGVGVVYNTR EHSQKFFLGH
61 NDDIISLALH PDKTLVATGQ VGKEPYICIW DSYNVQTVSL LKDVHTHGVA CLAFDSDGQR
121 LASVGLDAKN TVCIWDWRKG KLLASATGHS DRIFDISWDP YQPNRVVSCG VKHIKFWTLC
181 GNALTAKRGI FGKTGDLQTI LCLACAKEDI TYSGALNGDI YVWKGLNLVR TIQGAHSAGI
241 FSMYACEEGF ATGGRDGCIR LWDTDFKPIT KIDLRETEQG YKGLSIRSVC WKADRLLAGT
301 QDSEIFEVIV RERDKPMLIL QGHCEGELWA LALHPKKPLA VTGSDDRSVR LWSLADHALI
361 ARCNMEEAVR SVAFSPDGSQ LALGMKDGSF IVLRVRDMTE VVHIKDRKEV IHEMKFSPDG
421 SYLAVGSNDG PVDVYAVAQR YKKIGECSKS LSFITHIDWS LDSKYLQTND GAGERLFYRM
481 PSGKPLTSKE EIKGIPWASW TCVKGPEVSG IWPKYTEVTD INSVDANYNS SVLVSGDDFG
541 LVKLFKFPCL KRGAKFRKYV GHSAHVTNVR WSHDFQWVLS TGGADHSVFQ WRFIPEGVSN
601 GMLETAPQEG GADSYSEESD SDLSDVPELD SDIEQEAQIN YDRQVYKEDL PQLKQQSKEK
661 NHAVPFLKRE KAPEDSLKLQ FIHGYRGYDC RNNLFYTQAG EVVYHIAAVA VVYNRQQHSQ
721 RLYLGHDDDI LSLTIHPVKD YVATGQVGRD AAIHVWDTQT LKCLSLLKGQ HQRGVCALDF
781 SADGKCLVSV GLDDFHSIVF WDWKKGEKIA TTRGHKDKIF VVKCNPHHVD KLVTVGIKHI
841 KFWQQAGGGF TSKRGTFGSV GKLETMMCVS YGRMEDLVFS GAATGDIFIW KDILLLKTVK
901 AHDGPVFAMY ALDKGFVTGG KDGIVELWDD MFERCLKTYA IKRSALSTSS KGLLLEDNPS
961 IRAITLGHGH ILVGTKNGEI LEIDKSGPMT LLVQGHMEGE VWGLAAHPLL PICATVSDDK
1021 TLRIWELSAQ HRMLAVRKLK KGGRCCAFSP DGKALAVGLN DGSFLVVNAD TVEDMVSFHH
1081 RKEMISDIKF SKDTGKYLAV ASHDNFVDIY NVLTSKRVGI CKGASSYITH IDWDSRGKLL
1141 QVNSGAREQL FFEAPRGKRH IIRPSEIEKI EWDTWTCVLG PTCEGIWPAH SDITDVNAAS
1201 LTKDCSLLAT GDDFGFVKLF SYPVKGQHAR FKKYVGHSAH VTNVRWLHND SVLLTVGGAD
1261 TALMIWTREF VGTQESKLVD SEESDTDVEE DGGYDSDVAR EKAIDYTTKI YAVSIREMEG
1321 TKPHQQLKEV SVEERPPVSR AAPQPEKLQK NNITKKKKLV EELALDHVFG YRGFDCRNNL
1381 HYLNDGADII FHTAAAGIVQ NLSTGSQSFY LEHTDDILCL TVNQHPKYRN VVATSQIGTT
1441 PSIHIWDAMT KHTLSMLRCF HSKGVNYINF SATGKLLVSV GVDPEHTITV WRWQEGAKVA
1501 SRGGHLERIF VVEFRPDSDT QFVSVGVKHM KFWTLAGSAL LYKKGVIGSL GAAKMQTMLS
1561 VAFGANNLTF TGAINGDVYV WKDHFLIRLV AKAHTGPVFT MYTTLRDGLI VTGGKERPTK
1621 EGGAVKLWDQ EMKRCRAFQL ETGQLVECVR SVCRGKGKIL VGTKDGEIIE VGEKNAASNI
1681 LIDGHMEGEI WGLATHPSKD LFISASNDGT ARIWDLADKK LLNKVSLGHA ARCAAYSPDG
1741 EMVAIGMKNG EFVILLVNSL KVWGKKRDRK SAIQDIRISP DNRFLAVGSS EHTVDFYDLT
1801 QGTNLNRIGY CKDIPSFVIQ MDFSADGKYI QVSTGAYKRQ VHEVPLGKQV TEAVVIEKIT
1861 WASWTSVLGD EVIGIWPRNA DKADVNCACV THAGLNIVTG DDFGLVKLFD FPCTEKFAKH
1921 KRYFGHSAHV TNIRFSYDDK YVVSTGGDDC SVFVWRCLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EML6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- retina: 11 nTPM
- tonsil: 8.9 nTPM
- lymph node: 6 nTPM
- appendix: 3.5 nTPM
- cerebellum: 3.2 nTPM
- pituitary gland: 2.8 nTPM
Single-cell type
- ependymal cells: 371 nCPM
- brain excitatory neurons: 284 nCPM
- brain inhibitory neurons: 259 nCPM
- retinal horizontal cells: 246 nCPM
- other brain neurons: 219 nCPM
- rod photoreceptor cells: 194 nCPM
Immune cell
- basophil: 0.7 nTPM
- memory B-cell: 0.4 nTPM
- naive B-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 12 nTPM
- white matter: 10 nTPM
- hypothalamus: 9 nTPM
- hippocampal formation: 8.5 nTPM
- basal ganglia: 7.9 nTPM
- midbrain: 7.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EML6.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 358 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on EML6 was assayed in.
- multiple sclerosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WD40 repeat
- HELP motif
- Quinoprotein alcohol dehydrogenase-like superfamily
- Cytochrome cd1-nitrite reductase-like, haem d1 domain superfamily
- WD40/YVTN repeat-like-containing domain superfamily
- WD40-repeat-containing domain superfamily
- WD repeat Echinoderm Microtubule-associated Protein-like
- EML-like, first beta-propeller domain
- EML-like, second beta-propeller domain
- HELP motif
- Echinoderm microtubule-associated protein first beta-propeller
- Echinoderm microtubule-associated protein second beta-propeller
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EML6 as an antibody target. Whether an autoantibody or antibody against EML6 could matter depends on whether native EML6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EML6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EML6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...